MIDAZOLAM and HYPOTENSION

Overview

HYPOTENSION is the #4 most commonly reported adverse reaction for MIDAZOLAM, manufactured by UCB, Inc.. There are 1,295 FDA adverse event reports linking MIDAZOLAM to HYPOTENSION. This represents approximately 3.0% of all 42,629 adverse event reports for this drug.

Patients taking MIDAZOLAM who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HYPOTENSION is a less commonly reported adverse event for MIDAZOLAM, but still significant enough to appear in the safety profile.

Other Side Effects of MIDAZOLAM

In addition to hypotension, the following adverse reactions have been reported for MIDAZOLAM:

• DRUG INEFFECTIVE — 2,985 reports
• OFF LABEL USE — 2,237 reports
• SEIZURE — 1,373 reports
• DRUG INTERACTION — 1,089 reports
• TOXICITY TO VARIOUS AGENTS — 846 reports
• ACUTE KIDNEY INJURY — 845 reports
• PYREXIA — 813 reports
• CARDIAC ARREST — 811 reports
• DEATH — 689 reports
• STATUS EPILEPTICUS — 629 reports

Other Drugs Associated with HYPOTENSION

The following drugs have also been linked to hypotension in FDA adverse event reports:

Does MIDAZOLAM cause HYPOTENSION?

HYPOTENSION has been reported as an adverse event in 1,295 FDA reports for MIDAZOLAM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HYPOTENSION with MIDAZOLAM?

HYPOTENSION accounts for approximately 3.0% of all adverse event reports for MIDAZOLAM, making it a notable side effect.

What should I do if I experience HYPOTENSION while taking MIDAZOLAM?

If you experience hypotension while taking MIDAZOLAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages